Facilitators and barriers to utilization of medications for opioid use disorder in primary care in South Carolina

被引:16
|
作者
Oros, Sarah M. [1 ,2 ]
Christon, Lillian M. [1 ]
Barth, Kelly S. [1 ]
Berini, Carole R. [3 ]
Padgett, Bennie L. [4 ]
Diaz, Vanessa A. [3 ]
机构
[1] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA
[2] Med Univ South Carolina, Dept Internal Med, Charleston, SC 29425 USA
[3] Med Univ South Carolina, Dept Family Med, Charleston, SC 29425 USA
[4] Med Univ South Carolina, Coll Med, Charleston, SC 29425 USA
来源
关键词
opioid use disorder; medication for opioid use disorder; primary care providers barriers; facilitators; internal medicine; family medicine; physician assistant; trainees; QUALITATIVE RESEARCH; UNITED-STATES; BUPRENORPHINE; SUBSTANCE; HEALTH; MANAGEMENT; ALCOHOL; INTERVIEWS; PREVENTION; CRITERIA;
D O I
10.1177/0091217420946240
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective Utilization of medications for opioid use disorder (MOUD) has not been widely adopted by primary care providers. This study sought to identify interprofessional barriers and facilitators for use of MOUD (specifically naltrexone and buprenorphine) among current and future primary care providers in a southeastern academic center in South Carolina. Method Faculty, residents, and students within family medicine, internal medicine, and a physician assistant program participated in focus group interviews, and completed a brief survey. Survey data were analyzed quantitatively, and focus group transcripts were analyzed using a deductive qualitative content analysis, based upon the theory of planned behavior. Results Seven groups (N = 46) completed focus group interviews and surveys. Survey results indicated that general attitudes towards MOUD were positive and did not differ significantly among groups. Subjective norms around prescribing and controllability (i.e., beliefs about whether prescribing was up to them) differed between specialties and between level of training groups. Focus group themes highlighted attitudes about MOUD (e.g., "opens the flood gates" to patients with addiction) and perceived facilitators and barriers of using MOUD in primary care settings. Participants felt that although MOUD in primary care would improve access and reduce stigma for patients, prescribing requires improved provider education and an integrated system of care. Conclusions The results of this study provide an argument for tailoring education to specifically address the barriers primary care prescribers perceive. Results promote the utilization of active, hands-on learning approaches, to ultimately promote uptake of MOUD prescribing in the primary care setting in South Carolina.
引用
收藏
页码:14 / 39
页数:26
相关论文
共 50 条
  • [31] Medications for Opioid Use Disorder Utilization Among Oxford House Residents
    John M. Majer
    Leonard A. Jason
    Joshua Norris
    Patrick Hickey
    Hayoung Jeong
    Ted J. Bobak
    Community Mental Health Journal, 2020, 56 : 925 - 932
  • [32] Barriers and Facilitators to Recruitment of a Multifaceted Population of Opioid Use Disorder Community Stakeholders
    Avery-Desmarais, Shannon
    Schuler, Monika
    Viveiros, Jennifer
    Mccurry, Mary
    Tyo, Mirinda
    Kauranen, Brianna
    JOURNAL OF ADDICTIONS NURSING, 2024, 35 (03) : 137 - 141
  • [33] Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care
    Chang, Evelyn T.
    Oberman, Rebecca S.
    Cohen, Amy N.
    Taylor, Stephanie L.
    Gumm, Elisa
    Mardian, Aram S.
    Toy, Shawn
    Revote, Araceli
    Lewkowitz, Britney
    Yano, Elizabeth M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 3) : 918 - 926
  • [34] Barriers and Facilitators to Expanding Buprenorphine Treatment for Opioid Use Disorder in Jail Settings
    Kelsch, Jordan
    McGladrey, Margaret
    Oser, Carrie
    Booty, Marisa
    Fanucchi, Laura
    Walsh, Sharon
    Lofwall, Michelle
    DRUG AND ALCOHOL DEPENDENCE, 2024, 260
  • [35] Prescribing and Acceptance of Medications for Opioid Use Disorder in VA Primary Care: Veteran and Provider Perspectives
    Bergman, Alicia A.
    Oberman, Rebecca S.
    Taylor, Stephanie L.
    Kranke, Bridget
    Chang, Evelyn T.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (09) : 1690 - 1697
  • [36] Increasing Access to Medications for Opioid Use Disorder and Complementary and Integrative Health Services in Primary Care
    Evelyn T. Chang
    Rebecca S. Oberman
    Amy N. Cohen
    Stephanie L. Taylor
    Elisa Gumm
    Aram S. Mardian
    Shawn Toy
    Araceli Revote
    Britney Lewkowitz
    Elizabeth M. Yano
    Journal of General Internal Medicine, 2020, 35 : 918 - 926
  • [37] 30-Month Impact of Medications for Opioid Use Disorder on Acute Care Utilization in Rural Communities
    Maeng, Daniel
    Russell, Holly A.
    Conner, Kenneth R.
    Malcho, Jade
    Cross, Wendi
    Lee, Hochang B.
    JOURNAL OF ADDICTION MEDICINE, 2025, 19 (02) : 143 - 149
  • [38] Barriers and facilitators to implementing changes in opioid prescribing in rural primary care clinics
    Parchman, Michael L.
    Ike, Brooke
    Osterhage, Katherine P.
    Baldwin, Laura-Mae
    Stephens, Kari A.
    Sutton, Sarah
    JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 4 (05) : 425 - 430
  • [39] Treatment of opioid use disorder in primary care
    Buresh, Megan
    Stern, Robert
    Rastegar, Darius
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [40] Treating opioid use disorder in primary care
    Perry, Danielle
    Orrantia, Eliseo
    Garrison, Scott
    CANADIAN FAMILY PHYSICIAN, 2019, 65 (02) : 117 - 117